AzTrials
AzTrials

ObesityNCT07032571

Reset: Enhancing Weight Loss in a Digital Intervention

A study testing Core Behavioral Weight Loss Intervention, Limit Red Zone Foods and Limit Eating Window in people with Obesity and Overweight, run by Stanford University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of the Reset trial is to learn about the optimal combination of dietary behavior strategies in a fully digital weight loss intervention. The intervention is designed for adults with overweight or obesity. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obesity, Overweight, Weight Loss
What is being tested?
Core Behavioral Weight Loss Intervention, Limit Red Zone Foods and Limit Eating Window
Could I receive a placebo?
No, everyone receives an active treatment
How many people
208 participants
Where
1 siteUnited States
Study dates
Sep 2026to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adults (ages 18+ years)
  • body mass index (BMI) 25.0 to 45.0 kg/m^2
  • cellphone ownership with a texting plan
  • daily access to a personal scale
  • daily access to a personal email account
  • English language proficiency
  • interest in losing weight through behavioral strategies
  • living in the United States

Who cannot join

  • concurrent enrollment in another weight management intervention
  • loss of ≥5% body weight in the past 6 months
  • current use of a weight loss or anti-obesity medication
  • prior or planned bariatric surgery in the next 3 months
  • current pregnancy, planned pregnancy in the next 3 months, or recent pregnancy in the past 6 months
  • current breastfeeding or lactating
Show all 13Show fewer
  • living with someone else participating in the study
  • hospitalization for a mental health condition in the past 12 months
  • inability to engage in moderate forms of physical activity akin to brisk walking
  • if weight loss is contraindicated or might be impacted by a condition (e.g., end stage renal disease, cancer, schizophrenia, dementia) or medication (e.g., steroids, antipsychotics)
  • if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus)
  • participation in another weight loss study conducted in Dr. Patel's lab in the past 6 months
  • investigator discretion for safety reasons

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Michele L Patel, PhD contact

650-549-7047

ResetStudy@stanford.edu

United States1 site
  • Stanford University School of Medicine

    Palo Alto, California, 94304

Other trials in United States

About this study

Official title: Enhancing Weight Loss in a Digital Intervention Among Adults With Overweight or Obesity

The goal of the Reset trial is to learn about the optimal combination of dietary behavior strategies in a fully digital weight loss intervention. The intervention is designed for adults with overweight or obesity. The investigators will examine the impact on weight loss of four dietary strategies: 1) limiting Red Zone Foods (i.e., foods that are high in calories and low in nutrition), 2) limiting eating windows, 3) increasing protein intake, and 4) increasing fiber intake. Each of these strategies will include goal setting, daily self-monitoring, and tailored feedback.

The investigators will recruit 208 participants. Broadly, adults with overweight or obesity who live in the U.S. will be eligible. The weight loss intervention will last 12 weeks. All participants will be asked to track their body weight daily and complete weekly behavioral lessons and action plans to promote healthy eating and physical activity. All study tasks will occur remotely. Assessment of body weight and survey measures will occur at the beginning of the trial ("baseline"), and at 1 month and 3 months.

The Multiphase Optimization Strategy (MOST) framework will be used to identify which combination of the dietary behavior strategies results in the greatest weight loss. In total, there will be 16 treatment conditions.

Being tested
Core Behavioral Weight Loss Intervention, Limit Red Zone Foods, Limit Eating Window, Increase Protein, Increase Fiber Intake
Keywords
obesity, overweight, weight loss, weight, health behavior, lifestyle intervention, lifestyle modification, multiphase optimization strategy, intervention, behavior change, weight reduction, lose weight, adults, BMI reduction, body fat reduction, weight control, weight change, weight management, obesity management, obesity treatment
Medical subject headings
Obesity, Overweight, Weight Loss, Health Behavior, Body Weight, Body Weight Changes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Core Behavioral Weight Loss InterventionBehavioural

    All participants receive a 12-week core behavioral weight loss intervention consisting of the following: daily self-monitoring of weight; weekly behavioral lessons and action plans to promote healthy eating and physical activity; and tailored feedback. The intervention will be delivered remotely via email and/or text message.

  • Limit Red Zone FoodsBehavioural

    Participants randomized to receive this component are given a goal to limit their Red Zone Foods (i.e., foods high in calories and low in nutrition) and are instructed to self-monitor them daily.

  • Limit Eating WindowBehavioural

    Participants randomized to receive this component are given a goal to limit their eating windows (i.e., follow time-restricted eating) and are instructed to self-monitor them daily.

  • Increase ProteinBehavioural

    Participants randomized to receive this component are given a goal to increase their protein intake and are instructed to self-monitor it daily.

  • Increase Fiber IntakeBehavioural

    Participants randomized to receive this component are given a goal to increase their fiber intake and are instructed to self-monitor it daily.

Study groups in NCT07032571
Study groupRoleWhat they receive
Condition 1ExperimentalCore Only
Receives: Behavioral: Core Behavioral Weight Loss Intervention
Condition 2ExperimentalCore + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Increase Fiber Intake
Condition 3ExperimentalCore + Increase Protein
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Increase Protein
Condition 4ExperimentalCore + Increase Protein + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Increase Protein; Behavioral: Increase Fiber Intake
Condition 5ExperimentalCore + Limit Eating Window
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Eating Window
Condition 6ExperimentalCore + Limit Eating Window + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Eating Window; Behavioral: Increase Fiber Intake
Condition 7ExperimentalCore + Limit Eating Window + Increase Protein
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Eating Window; Behavioral: Increase Protein
Condition 8ExperimentalCore + Limit Eating Window + Increase Protein + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Eating Window; Behavioral: Increase Protein; Behavioral: Increase Fiber Intake
Condition 9ExperimentalCore + Limit Red Zone Foods
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods
Condition 10ExperimentalCore + Limit Red Zone Foods + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Increase Fiber Intake
Condition 11ExperimentalCore + Limit Red Zone Foods + Increase Protein
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Increase Protein
Condition 12ExperimentalCore + Limit Red Zone Foods + Increase Protein + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Increase Protein; Behavioral: Increase Fiber Intake
Condition 13ExperimentalCore + Limit Red Zone Foods + Limit Eating Window
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Limit Eating Window
Condition 14ExperimentalCore + Limit Red Zone Foods + Limit Eating Window + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Limit Eating Window; Behavioral: Increase Fiber Intake
Condition 15ExperimentalCore + Limit Red Zone Foods + Limit Eating Window + Increase Protein
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Limit Eating Window; Behavioral: Increase Protein
Condition 16ExperimentalCore + Limit Red Zone Foods + Limit Eating Window + Increase Protein + Increase Fiber
Receives: Behavioral: Core Behavioral Weight Loss Intervention; Behavioral: Limit Red Zone Foods; Behavioral: Limit Eating Window; Behavioral: Increase Protein; Behavioral: Increase Fiber Intake

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight Change from Baseline to 3 Months

    mean change in kg; assessed via participants' personal scales

    Measured: Baseline and 3 Months

Secondary outcomes (4)
  1. Weight Change from Baseline to 1 Month

    mean change in kg; assessed via participants' personal scales

    Measured: Baseline and 1 Month

  2. Clinically Significant Weight Loss at 3 Months

    operationalized as the proportion of participants achieving ≥5% weight loss from baseline

    Measured: 3 Months

  3. Moderate-to-Vigorous Physical Activity (MVPA) Change from Baseline to 3 Months

    mean change; assessed via the Godin Leisure-Time Exercise Questionnaire (GLTEQ)'s MVPA Score Index. The GLTEQ is a self-report measure that assesses a typical week's frequency of engaging in different types of exercise (strenuous, moderate, mild/light) for at least 15 minutes. Minimum score is 0. Higher scores indicate more frequent exercise. Scores ≥ 24 indicate "active" while scores < 24 indicate "insufficiently active."

    Measured: Baseline and 3 Months

  4. Caloric Intake Change from Baseline to 3 Months

    mean change in kilocalories; assessed via the Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24): 2 separate 24-hour diet recalls per time point: 1 week day, 1 weekend day

    Measured: Baseline and 3 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2025
  2. Study startSep 2026 (estimated)
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
This study uses a full factorial experimental design to test the impact of four intervention components, each with two levels, on vs. off (i.e., a 2x2x2x2, or 2\^4 factorial design).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
208 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07032571
Sponsor's protocol ID
81144
Status last verified
Aug 2026
First submitted
15 Jun 2025
Last updated
4 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The de-identified dataset and metadata will be made available through a public repository. It will include the primary outcome (weight change), secondary outcomes, and participant level characteristics. Data will be available in an Excel spreadsheet, whereby each row corresponds to a unique participant's data, and columns represent the different variables mentioned, by time point.

Questions about this trial

What is this clinical trial studying?

A study testing Core Behavioral Weight Loss Intervention, Limit Red Zone Foods and Limit Eating Window in people with Obesity and Overweight, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michele L Patel, PhD (650-549-7047, ResetStudy@stanford.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight Change from Baseline to 3 Months (time frame: Baseline and 3 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Reset: Enhancing Weight Loss in a Digital Intervention | AzTrials